Ignite Creation Date:
2024-05-06 @ 9:49 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03082040
Status:
COMPLETED
Last Update Posted:
2020-06-05
First Post:
2017-03-06
Brief Title:
A Home-based Breathing Training on Menopausal Symptoms
Sponsor:
Ministry of Science and Technology Taiwan
Organization:
Ministry of Science and Technology Taiwan
Study Overview
Official Title:
Effects of a Home-based Breathing Training on Menopausal Symptoms Among Community Menopausal Women
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective triple-blinded and randomized controlled trial examining the effects of a home-based breathing training assisted with biofeedback on menopausal symptoms and autonomic functions among community menopausal women We also examines whether the changes in autonomic functions would be mediators between slow breathing and menopausal symptoms This study will include menopausal women aged from 45 to 64 who experienced menopausal symptoms Participants will be randomly assigned to either an intervention group n 80 or a waiting-list control group n 80 The intervention group will undergo the home-based breathing training 20 minutes twice daily and participants in the control condition will participate the same breathing training after a four-week waiting list period The primary outcome measures are menopausal symptoms measured by symptom diaries of menopausal symptoms and the Greene Climacteric Scale GCS Secondary outcome measures are autonomic functions expressed by blood pressure BP heart rate HR and heart rate variability HRV Measurements will be taken at baseline week 4 and week 8
Detailed Description:
Ditto
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None